πŸ‡ΊπŸ‡Έ FDA
Patent

US 11306130

PAR3 mimetic peptides and uses thereof

granted A61KA61K47/542A61K47/543

Quick answer

US patent 11306130 (PAR3 mimetic peptides and uses thereof) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K47/542, A61K47/543, A61K47/60, A61K47/61